Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS
Clinical trial NCT03334786 · TERMINATED
Trial details
- NCT number
- NCT03334786
- Sponsor
- Flex Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2018-08-23
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.